Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Genome Editing Builds Viral Disease Resistance in Pigs

Veterinary researchers used Crispr-Cas9, an emerging genome editing technique, to produce pigs with cells resistant to a common viral disease affecting commercial herds. . . . → Read More: Genome Editing Builds Viral Disease Resistance in Pigs

Biofeedback Device Reduces Panic Attacks in Trial

A medical device that provides people with panic disorder feedback on their abnormal breathing is shown in a clinical trial to reduce panic severity 12 months after treatment. . . . → Read More: Biofeedback Device Reduces Panic Attacks in Trial

Smart Watch Data Reveal Epilepsy Triggers

Data collected with Apple smart watches show stress and missed sleep tend to trigger more seizures among people with epilepsy than other causes. . . . → Read More: Smart Watch Data Reveal Epilepsy Triggers

Patent Issued for Peptides in Diabetes Gene Therapy

A U.S. patent was issued today for synthetic peptides that support gene therapies developed to treat type 2 diabetes and heart failure. . . . → Read More: Patent Issued for Peptides in Diabetes Gene Therapy

Slot Machine Gamblers Get Hooked in Trance-Like State

Findings from a recent study show gamblers who get immersed in playing slot machines are more at risk to develop gambling problems as a result. . . . → Read More: Slot Machine Gamblers Get Hooked in Trance-Like State

Stem Cells Launched on Current SpaceX Flight

Yesterday’s SpaceX launch from NASA’s Kennedy Spaceflight Center includes a shipment of adult stem cells to test their growth and proliferation in weightless conditions. . . . → Read More: Stem Cells Launched on Current SpaceX Flight

Patent Office Decides for Broad and Editas in Crispr Case

The U.S. Patent and Trademark Office decided that the gene editing processes developed by Broad Institute and licensed to Editas Medicine do not interfere with techniques for genome editing created by University of California at Berkeley. . . . → Read More: Patent Office Decides for Broad and Editas in Crispr Case

Tissue Regeneration Start-Up Gains $33M in Early Funds

A new enterprise founded by researchers at Stanford University aims to discover and develop drugs that repair and regenerate tissue from stem cells. . . . → Read More: Tissue Regeneration Start-Up Gains $33M in Early Funds

Biotech Group Withholds Support for Germline Trial Report

A biotechnology industry association in the U.S. says its members are not ready to support recommendations in a new report permitting future clinical studies of genome editing for inheritable disease-causing traits. . . . → Read More: Biotech Group Withholds Support for Germline Trial Report

Skin Health Data Collected by App Offered for Research

A smartphone app collecting images and data about moles on the skin of volunteers is now available to researchers for studies of cancer and other disorders. . . . → Read More: Skin Health Data Collected by App Offered for Research